Hospital Mater Dei (BSP:MATD3) Change In Receivables: R$-103 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:MATD3 Hospital Mater Dei SA BSP:MATD3
85 GF Score
Price R$4.91
GF Value R$5.89
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Hospital Mater Dei Change In Receivables?

Hospital Mater Dei BSP:MATD3 +1.45% 85 Change In Receivables is R$-103 Mil as of Mar. 2026. GuruFocus rates BSP:MATD3 with a GF Score™ of 85/100 and a GF Value™ of R$5.89 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Hospital Mater Dei's change in receivables for the quarter that ended in Mar. 2026 was R$-62 Mil. It means Hospital Mater Dei's Accounts Receivable increased by R$62 Mil from Dec. 2025 to Mar. 2026 .

Hospital Mater Dei's change in receivables for the fiscal year that ended in Dec. 2025 was R$-58 Mil. It means Hospital Mater Dei's Accounts Receivable increased by R$58 Mil from Dec. 2024 to Dec. 2025 .

Hospital Mater Dei's Accounts Receivable for the quarter that ended in Mar. 2026 was R$974 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Hospital Mater Dei's Days Sales Outstanding for the three months ended in Mar. 2026 was 154.55.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Hospital Mater Dei's liquidation value for the three months ended in Mar. 2026 was R$-1,469 Mil.

Hospital Mater Dei  (BSP:MATD3) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Hospital Mater Dei's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=973.816/574.958*91
=154.55

2. In Ben Graham's calculation of liquidation value, Hospital Mater Dei's accounts receivable are only considered to be worth 75% of book value:

Hospital Mater Dei's liquidation value for the quarter that ended in Mar. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=583.971-2823.27+0.75 * 973.816+0.5 * 78.882
=-1,469

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hospital Mater Dei Change In Receivables Related Terms

Hospital Mater Dei Change In Receivables Historical Data

* Premium members only.

The historical data trend for Hospital Mater Dei's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hospital Mater Dei Change In Receivables Chart

Hospital Mater Dei Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only 68.15 -143.56 -212.13 -159.02 -58.01

Hospital Mater Dei Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.34 -27.96 -22.52 9.81 -61.93
BSP:MATD3
85GF Score
Hospital Mater Dei SA BSP:MATD3
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hospital Mater Dei Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-103 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of R$-103 Mil mean?
Hospital Mater Dei (BSP:MATD3) has a Change In Receivables of R$-103 Mil as of Mar. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Hospital Mater Dei and its competitors.
Is Hospital Mater Dei's Change In Receivables too high?
Hospital Mater Dei's current Change In Receivables is R$-103 Mil. Overall, Hospital Mater Dei has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's Change In Receivables compare to HCA and THC?
Hospital Mater Dei's Change In Receivables of R$-103 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Healthcare Providers & Services company?
A good Change In Receivables depends on the Healthcare Providers & Services industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Hospital Mater Dei and its competitors. Hospital Mater Dei's current Change In Receivables is R$-103 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$5.89, compared to a current price of R$4.91 — trading 16.6% below its estimated fair value. The current Change In Receivables is R$-103 Mil. Hospital Mater Dei's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current Change In Receivables is R$-103 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?

Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued. The current stock price of R$4.91 is trading 16.6% below its estimated GF Value™ of R$5.89. GuruFocus considers Hospital Mater Dei to be Modestly Undervalued.

Key valuation signals for BSP:MATD3:

  • Change In Receivables: R$-103 Mil
  • GF Value™: R$5.89 vs. price of R$4.91 (16.6% below fair value)
  • GF Score™: 85/100 with 3 warning signs

No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hospital Mater Dei Business Description

Address Rua Mato Grosso, No. 1, 100, Bairro Santo Agostinho, Belo Horizonte, MG, BRA, 30.190-081
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
85GF Score

Get the complete analysis for BSP:MATD3

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$4.91
Price
R$5.89
GF Value